[The evaluation of ceftibuten (Cedax) effectiveness in the prevention of perioperative infections]

Otolaryngol Pol. 1997;51(4):390-5.
[Article in Polish]

Abstract

Cedax is the antibiotic drug of the third generation cephalosporin type. In the Department of Otolaryngology of the University Medical School in Poznań tests were carried out on the effectiveness of this drug in the prevention of perioperative infections (tonsillectomy, adenotomy, septoplastics, nasal polypectomy, mucotomy). The experiment comprised 50 patients who were administered Cedax once a day of the period of five consecutive days, beginning on the day of the surgery. Control group compare 50 patients who did not receive the antibiotic cover. For the comparison of both groups the following symptoms were taken into account: general condition of the patient, body temperature in the first few days after the surgery, the healing of the operative wound (the condition of mucosa, healing "per primam" or "per secundam"), the presence and type of nasal discharge. A high degree of efficiency of ceftibuten has observed.

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial

MeSH terms

  • Adult
  • Ceftibuten
  • Cephalosporins / therapeutic use*
  • Child
  • Child, Preschool
  • Female
  • Gram-Negative Bacterial Infections / prevention & control*
  • Humans
  • Male
  • Surgical Wound Infection / prevention & control*

Substances

  • Cephalosporins
  • Ceftibuten